Literature DB >> 4109546

Association of fibrinogen-fibrin-related antigen (F.R.-antigen) with postoperative deep-vein thrombosis and systemic complications.

E H Wood, C R Prentice, G P McNicol.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4109546     DOI: 10.1016/s0140-6736(72)90568-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Disseminated intravascular coagulation: a review.

Authors:  P J Hamilton; A L Stalker; A S Douglas
Journal:  J Clin Pathol       Date:  1978-07       Impact factor: 3.411

2.  Postpartum purpura fulminans: successful management with streptokinase.

Authors:  F E Preston; I R Edwards
Journal:  Br Med J       Date:  1973-08-11

3.  Measurement of fibrinogen-fibrin-related antigen in serum as aid to diagnosis of deep vein thrombosis in outpatients.

Authors:  D A Tibbutt; C N Chesterman; M J Allington; E W Williams; T Faulkner
Journal:  Br Med J       Date:  1975-02-15

Review 4.  Epidemiology of venous thromboembolism.

Authors:  W W Coon
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

5.  The incidence of deep vein thrombosis in prostatectomised patients following the administration of the fibrinolytic inhibitor, aminocaproic acid (EACA).

Authors:  J Sinclair; C D Forbes; C R Prentice; R Scott
Journal:  Urol Res       Date:  1976-11-10

6.  Low-dosage ancrod for prevention of thrombotic complications after surgery for fractured neck of femur.

Authors:  W W Barrie; E H Wood; P Crumlish; C D Forbes; C R Prentice
Journal:  Br Med J       Date:  1974-10-19

7.  Serum and urine fibrinogen-fibrin-related antigen (F.R.-antigen) levels in renal disease.

Authors:  J D Briggs; C R Prentice; M M Hutton; A C Kennedy; G P McNicol
Journal:  Br Med J       Date:  1972-10-14

8.  The effect of age on the fibrinolytic enzyme system.

Authors:  P J Hamilton; A A Dawson; D Ogston; A S Douglas
Journal:  J Clin Pathol       Date:  1974-04       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.